Tech Company Financing Transactions

Indapta Therapeutics Funding Round

Indapta Therapeutics, based in San Francisco, secured $50 million in investment from Leaps by Bayer, RA Capital and Vertex Ventures HC.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

Undisclosed
San Francisco, CA 94105
USA

Phone

Undisclosed

Website

www.indapta.com

Email Address

[email protected]

Overview

Indapta is a biotechnology company seeking to harness the natural power of the immune system to fight hematologic and solid cancers with our universal G-NK cell platform. Headquartered in San Francisco, Indapta was founded in 2017 by Guy DiPierro along with Ronald Martell and scientists at the University of California, Davis, and Stanford University.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chairman

Ronald Martell

        

Chief Executive Officer

Mark Frohlich

        

VP - Bus. Development

Guy Dipierro

        

VP - Bus. Development

Lori Kunkel

        

VP - R & D

Austin Bigley

        

VP - Regulatory Affairs

Elana Van Oudenaren

        

Browse more venture capital transactions:

Prev: 2/24/2022: Okteto venture capital transaction
Next: 2/24/2022: Expressable venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary